DEA Cracks Down on Fentanyl's Secret Ingredient: Propionyl Chloride Banned
Published Date: 3/10/2026
Rule
Summary
Starting April 9, 2026, propionyl chloride will be officially controlled because it’s used to make illegal fentanyl. Anyone who handles this chemical must register with the DEA and follow new rules, no matter how much they have. This change helps stop dangerous drug production while keeping businesses informed and ready.
Analyzed Economic Effects
9 provisions identified: 1 benefits, 6 costs, 2 mixed.
Must register to handle propionyl chloride
Starting April 9, 2026, anyone who manufactures, distributes, imports, or exports propionyl chloride (including regulated mixtures) must register with the DEA. The rule states separate registrations are required for manufacturing, distributing, importing, and exporting and for each principal place of business.
Registration fees specified
DEA lists annual registration fees of $3,699 for manufacturers and $1,850 for distributors, importers, and exporters. These fees apply to those who must register to handle propionyl chloride.
All quantities and mixtures regulated — no threshold
The rule sets no quantity threshold: all transactions of propionyl chloride are regulated regardless of size, and chemical mixtures containing any amount of propionyl chloride are not exempt at any concentration. The Table of Concentration Limits is amended to state mixtures containing any amount are not exempt.
Temporary registration exemption but reporting rules effective immediately
DEA provides a temporary exemption from the registration requirement if a properly completed registration application or application for mixture exemption is received on or before 30 days after publication of the final rule (i.e., by April 9, 2026). However, all other chemical control requirements, including recordkeeping and reporting, are effective on April 9, 2026.
New recordkeeping, reporting, security, and inspection rules
From April 9, 2026, registrants must maintain records for two years, submit annual manufacturing/inventory/use data if a regulated bulk manufacturer, report suspicious or extraordinary transactions, implement security controls per 21 CFR 1309.71-1309.73, and allow administrative inspections of controlled premises.
Violations subject to civil and criminal penalties
Any activity involving propionyl chloride that is not authorized by or violates the CSA would be unlawful and could subject the person to administrative, civil, and/or criminal action under federal law.
Small number of domestic distributors affected
DEA identified 20 domestic distributors of propionyl chloride; three are already registered and 17 are not registered. DEA notes those 17 are small entities and estimates they represent 0.19% of U.S. businesses in the NAICS 424690 industry; some nonregistered suppliers may stop selling rather than register.
Chemical mixture exemption application process
Manufacturers may apply for an exemption of mixtures under 21 CFR 1310.13; DEA may grant an exemption by final rule if the mixture cannot be easily used for illicit production and the listed chemical cannot be readily recovered.
Warehousemen limited possession exemption
Warehouse operators may lawfully possess list I chemicals without registering if possession is in the usual course of business and they receive the chemical from a DEA registrant and only distribute it back to that registrant and registered location; distributing to others requires registration.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-10090 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) reviewed and decided on applications for special chemical mixtures that don’t fall under strict drug rules, covering requests from July 2025 to March 2026. Some mixtures got approved, others denied, and a few listings were fixed from earlier notices. If you’re involved with these chemicals, you’ve got until July 20, 2026, to share your thoughts—no fees or big costs involved, just your voice!
2026-09566 — Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Starting May 13, 2026, the DEA officially puts CUMYL-PEGACLONE—a chemical that can be risky—into Schedule I, the strictest drug category. This means anyone making, selling, or using it now faces tough rules and penalties. This move helps the U.S. follow international drug laws and keeps communities safer without any new fees or costs.
2026-08595 — Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
The DEA is giving hexahydrocannabinol (HHC) its own official spot on the list of Schedule I drugs, making it clear that HHC is controlled separately from other similar substances. This change starts May 4, 2026, and affects anyone making, selling, or using HHC, which stays illegal under federal law. No new fees or costs are introduced, but the update helps law enforcement and businesses know exactly where HHC stands.
2026-08587 — Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.
ANI Pharmaceuticals wants to import certain controlled drugs like Levorphanol and Tapentadol. People who make or use these drugs can share their thoughts or ask for a hearing by June 3, 2026. This move could affect drug availability and regulation, so keep an eye on the deadline to have your say!
2026-08588 — Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Patheon API Inc. wants to make large amounts of special research drugs like dimethyltryptamine and psilocybin. This affects researchers and companies involved in clinical trials, with a chance to comment or ask for a hearing by July 6, 2026. No money changes are mentioned, but this move could speed up important medical studies.
Previous / Next Documents
Previous: 2026-04649 — Air Plan Approval; North Dakota; Approval of Air Quality Implementation Plans; Regional Haze State Implementation Plan; Regional Haze Five Year Progress Report and Nitrogen Oxides Best Available Retrofit Technology Determination for Coal Creek Station for the First Implementation Period
The EPA is giving a thumbs-up to North Dakota’s plan to cut air pollution from the Coal Creek power plant, especially nitrogen oxides, as part of a regional haze cleanup effort. This approval also covers North Dakota’s five-year progress report on improving air quality. The new rule kicks in on April 9, 2026, helping protect the environment and public health while following court orders.
Next: 2026-04677 — Airworthiness Directives; Airbus SAS Airplanes
The FAA is updating rules for certain Airbus A319, A320, and A321 planes because some engines stalled during takeoff in freezing fog. Pilots must update their flight manuals by March 25, 2026, to keep flights safe. This change helps prevent accidents without big costs but needs quick action from airlines.